1. Home
  2. MKTW vs MYO Comparison

MKTW vs MYO Comparison

Compare MKTW & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarketWise Inc.

MKTW

MarketWise Inc.

N/A

Current Price

$15.10

Market Cap

36.4M

Sector

Technology

ML Signal

N/A

Logo Myomo Inc.

MYO

Myomo Inc.

N/A

Current Price

$0.70

Market Cap

36.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MKTW
MYO
Founded
1999
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.4M
36.9M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
MKTW
MYO
Price
$15.10
$0.70
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$20.00
$7.67
AVG Volume (30 Days)
9.3K
367.8K
Earning Date
06-08-2026
06-09-2026
Dividend Yield
12.13%
N/A
EPS Growth
1183.33
N/A
EPS
2.31
N/A
Revenue
$512,403,000.00
$1,000,000,000.00
Revenue This Year
N/A
$24.07
Revenue Next Year
N/A
$17.48
P/E Ratio
$6.42
N/A
Revenue Growth
N/A
40814.79
52 Week Low
$0.48
$0.64
52 Week High
$21.74
$6.27

Technical Indicators

Market Signals
Indicator
MKTW
MYO
Relative Strength Index (RSI) 51.93 38.18
Support Level $13.22 $0.64
Resistance Level $17.39 $1.03
Average True Range (ATR) 0.79 0.06
MACD 0.17 0.00
Stochastic Oscillator 57.30 23.90

Price Performance

Historical Comparison
MKTW
MYO

About MKTW MarketWise Inc.

Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: